EUVIMEDEUVIMED entdecken
Vergleichsstudie

Prospective Study Comparing [ 99m Tc]Tc-DP-FAPI Quantitative SPECT/CT with [ 68 Ga]Ga-FAPI-04 PET/CT in Patients with Gastrointestinal Tumors

Cheng Zhou iD, Guoquan Li, Zhiyong Quan, Zongke Deng, Guiyu Li, Mingru Zhang iD, Fei Kang, Weidong Yang, Jing Wang iD

Molecular Pharmaceutics · 07.10.2024 · 21 (10) · 5297-5304

DOI: 10.1021/acs.molpharmaceut.4c00783 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.09.2024. Verfasst von Cheng Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Milit…. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals, Gallium Radioisotopes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, [68Ga]Ga-FAPI-04 positron emission tomography (PET)/CT imaging has been widely used for the treatment of various tumors. However, the application of 99mTC-labeled fibroblast activation protein inhibitors in tumors has been less studied. Our team previously demonstrated the safe biological distribution of [99mTc]Tc-DP-FAPI in the human body. Based on this, this study reports the accuracy of [99mTc]Tc-DP-FAPI in the imaging diagnosis of gastrointestinal tumors and compares it with that of [68Ga]Ga-FAPI-04 to evaluate the differences. A total of 24 patients with clinically diagnosed gastrointestinal tumors were prospectively included. All patients received [99mTc]Tc-DP-FAPI quantitative SPECT/CT imaging on the first day and [68Ga]Ga-FAPI-04 PET/CT imaging on the second day. And the effectiveness of the two imaging probes in detecting suspicious lesions was analyzed and compared. The primary tumors of all 24 patients were well detected by two imaging probes, and the sensitivity of [99mTc]Tc-DP-FAPI and [68Ga]Ga-FAPI-04 to the primary lesions was 100%. [99mTc]Tc-DP-FAPI examined 21 lymph nodes with a sensitivity and specificity of 32.8% and 10.9%, and [68Ga]Ga-FAPI-04 detected 57 lymph nodes with a sensitivity and specificity of 89.1% and 67.2%, respectively. Three distant metastases were detected by [99mTc]Tc-DP-FAPI and nine metastases by [68Ga]Ga-FAPI-04. The study showed that [99mTc]Tc-DP-FAPI is highly sensitive to detecting primary lesions of gastrointestinal tumors. Compared with [68Ga]Ga-FAPI-04, [99mTc]Tc-DP-FAPI has the same sensitivity in detecting primary tumors but has certain limitations in detecting metastases. [99mTc]Tc-DP-FAPI is of great value for preliminary screening of tumor lesions and early diagnosis of disease in patients who are suspected of having gastrointestinal tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsGallium RadioisotopesHumansFemaleMaleMiddle AgedAgedProspective StudiesAdultOrganotechnetium CompoundsAged, 80 and overSingle Photon Emission Computed Tomography Computed TomographyLymphatic MetastasisQuinolines

Stichwörter der Autor:innen

Tc-99mfibroblast activation protein inhibitors (FAPI)gastrointestinal tumorsprospective studyquantitative SPECT/CT

Substanzen

RadiopharmaceuticalsGallium Radioisotopes68Ga-FAPIOrganotechnetium CompoundsQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710000, China.

ORCID-Profile: Cheng Zhou, Mingru Zhang, Jing Wang

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Projects of Shaanxi Province

Zitieren

APA

Zhou, C., Li, G., Quan, Z., Deng, Z., Li, G., Zhang, M., Kang, F., Yang, W., & Wang, J. (2024). Prospective Study Comparing [ 99m Tc]Tc-DP-FAPI Quantitative SPECT/CT with [ 68 Ga]Ga-FAPI-04 PET/CT in Patients with Gastrointestinal Tumors. Molecular Pharmaceutics, 21(10), 5297-5304. https://doi.org/10.1021/acs.molpharmaceut.4c00783

Vancouver

Zhou C, Li G, Quan Z, Deng Z, Li G, Zhang M, et al. Prospective Study Comparing [ 99m Tc]Tc-DP-FAPI Quantitative SPECT/CT with [ 68 Ga]Ga-FAPI-04 PET/CT in Patients with Gastrointestinal Tumors. Molecular Pharmaceutics. 2024;21(10):5297-5304. doi:10.1021/acs.molpharmaceut.4c00783

BibTeX
@article{Zhou2024,
  author = {Zhou, Cheng and Li, Guoquan and Quan, Zhiyong and Deng, Zongke and Li, Guiyu and Zhang, Mingru and Kang, Fei and Yang, Weidong and Wang, Jing},
  title = {Prospective Study Comparing [ 99m Tc]Tc-DP-FAPI Quantitative SPECT/CT with [ 68 Ga]Ga-FAPI-04 PET/CT in Patients with Gastrointestinal Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {10},
  pages = {5297--5304},
  doi = {10.1021/acs.molpharmaceut.4c00783}
}
Kostenlos starten →